Crucial Insights on Patent Litigation Strategies in Pharma Industry

In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. The focus of the discussion is on patent litigation strategies within the pharmaceutical industry, particularly concerning biosimilars versus generics and the complexities involved. Hakan begins by distinguishing between generics, typically small-molecule drugs, and biosimilars, which […] Source